Literature DB >> 7787470

Cardiac rehabilitation, exercise training, and preventive cardiology research at Ochsner Heart and Vascular Institute.

C J Lavie1, R V Milani, H O Ventura, F H Messerli, J P Murgo.   

Abstract

We review data from our institution demonstrating the benefits of cardiac rehabilitation and exercise training on coronary risk factors, exercise capacity, behavioral characteristics, and quality of life in various subgroups of patients. In addition, we discuss our research in several other areas of preventive cardiology, including lipid disorders, hypertension, left ventricular hypertrophy, fish oils, and antioxidants. We believe that we are now in a very exciting era in which a multifactorial approach to the primary and secondary prevention of coronary artery disease is needed in order to further reduce morbidity and mortality rates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787470      PMCID: PMC325210     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  28 in total

1.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

2.  Marked benefit with sustained-release niacin therapy in patients with "isolated" very low levels of high-density lipoprotein cholesterol and coronary artery disease.

Authors:  C J Lavie; L Mailander; R V Milani
Journal:  Am J Cardiol       Date:  1992-04-15       Impact factor: 2.778

3.  National Cholesterol Education Program's recommendations, and implications of "missing" high-density lipoprotein cholesterol in cardiac rehabilitation programs.

Authors:  C J Lavie; R V Milani
Journal:  Am J Cardiol       Date:  1991-10-15       Impact factor: 2.778

Review 4.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

Review 5.  Dietary prevention of coronary artery disease. How to help patients modify eating habits and reduce cholesterol.

Authors:  J H O'Keefe; C J Lavie; J O O'Keefe
Journal:  Postgrad Med       Date:  1989-05-01       Impact factor: 3.840

Review 6.  Cardiovascular rehabilitation: status, 1990.

Authors:  R W Squires; G T Gau; T D Miller; T G Allison; C J Lavie
Journal:  Mayo Clin Proc       Date:  1990-05       Impact factor: 7.616

7.  Hypertensive concentric left ventricular hypertrophy: when is ventricular ectopic activity increased?

Authors:  C J Lavie; B D Nunez; G E Garavaglia; F H Messerli
Journal:  South Med J       Date:  1988-06       Impact factor: 0.954

8.  Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity.

Authors:  C J Lavie; C Amodeo; H O Ventura; F H Messerli
Journal:  Chest       Date:  1987-12       Impact factor: 9.410

Review 9.  High-density lipoprotein cholesterol. Recommendations for routine testing and treatment.

Authors:  C J Lavie; J H O'Keefe; L Blonde; G T Gau
Journal:  Postgrad Med       Date:  1990-05-15       Impact factor: 3.840

Review 10.  Management of lipids in primary and secondary prevention of cardiovascular diseases.

Authors:  C J Lavie; G T Gau; R W Squires; B A Kottke
Journal:  Mayo Clin Proc       Date:  1988-06       Impact factor: 7.616

View more
  2 in total

1.  Preventive cardiology and non-invasive cardiology research at the ochsner clinic foundation.

Authors:  Carl J Lavie; Richard V Milani; Yvonne Gilliland; J Alberto Bernal; Homeyar Dinshaw; Hector O Ventura
Journal:  Ochsner J       Date:  2006

2.  Cardiopulmonary Rehabilitation, Exercise Training, and Preventive Cardiology: An Overview of a Decade of Research at the Ochsner Heart and Vascular Institute: Presented in part at Grand Rounds, Research Series, Ochsner Medical Institutions, May 17, 1999.

Authors:  C J Lavie; R V Milani; M M Cassidy; Y E Gilliland; J A Bernal
Journal:  Ochsner J       Date:  1999-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.